PetMed Express (NASDAQ:PETS) Shares Pass Above 200-Day Moving Average – Time to Sell?

Shares of PetMed Express, Inc. (NASDAQ:PETS) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $4.14 and traded as high as $4.93. PetMed Express shares last traded at $4.64, with a volume of 345,642 shares.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.

PetMed Express Stock Down 3.7 %

The stock’s fifty day simple moving average is $4.96 and its 200-day simple moving average is $4.14. The company has a market capitalization of $95.88 million, a PE ratio of -77.33 and a beta of 0.71.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million during the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. Analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current year.

Insider Activity

In other PetMed Express news, Director Leslie C.G. Campbell purchased 15,000 shares of the stock in a transaction dated Wednesday, December 4th. The shares were acquired at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the transaction, the director now directly owns 70,000 shares of the company’s stock, valued at $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On PetMed Express

A number of institutional investors and hedge funds have recently bought and sold shares of PETS. Sei Investments Co. raised its holdings in shares of PetMed Express by 8.3% in the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock worth $179,000 after acquiring an additional 3,400 shares during the last quarter. Point72 DIFC Ltd purchased a new stake in PetMed Express during the 2nd quarter worth about $34,000. Marshall Wace LLP purchased a new stake in PetMed Express during the 2nd quarter worth about $46,000. Independent Advisor Alliance acquired a new position in PetMed Express in the 3rd quarter valued at about $106,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in PetMed Express in the 2nd quarter valued at about $135,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.